Document is current
Any future updates will be listed below
-
Authors
Kristiansson, Amanda
Vilhelmsson Timmermand, Oskar
Altai, Mohamed
Strand, Sven-Erik
Åkerström, Bo
Örbom, Anders
-
Funding
Funding for this research was provided by:
Crafoordska Stiftelsen
Fru Berta Kamprads Stiftelse
Cancerfonden (190470Pj and 211836Pj)
Lund University
- License Information
-
More Information
Article History
Received: 5 December 2023
Accepted: 6 May 2024
First Online: 11 May 2024
Competing interests
: B.Å. is co-founder and shareholder of Guard Therapeutics International AB (formerly A1M Pharma AB), which holds patent rights on medical uses of A1M.
